复方甲氧那明胶囊治疗呼吸道感染后咳嗽的效果Meta分析

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To evaluate the effectiveness and safety of Compound Methenamin Capsules in the treatment of cough after respiratory infection. Methods Databases such as PubMed, Wanfang, CQVIP, and China National Knowledge Infrastructure (CNKI) were searched by computer from the establishment to July 3, 2019. The randomized controlled trials involving Compound Methenamin Capsules in the treatment of cough after respiratory infection were included, and Revman 5.3 was used for data analysis. Results There were 9 studies with a total of 1340 patients. Metaanalysis results showed that the total effective rate of the treatment group was higher than that of the control group, and the difference was statistically significant (RR=1.15, 95%CI [1.11, 1.19], P＜0.000 01). The cough score of the treatment group after treatment was lower than that of the control group, and the difference was statistically significant (MD=-0.34,95%CI [-0.41, -0.28], P＜0.000 01). There was no statistically significant difference in the incidence rate of adverse reactions between the two groups (RR=0.73, 95%CI [0.37, 1.47], P=0.38). Conclusion Compound Methenamin Capsules are effective and safe in the treatment of cough after respiratory infection. However, due to the small sample size and low quality of existing studies,more large-sample,high-quality and multi-center clinical studies are needed to confirm it.

Key words： Cough after respiratory infection Compound Methenamin Capsules Treatment Meta-analysis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Yu-dou
	YUAN Xia

Cite this article:

ZHANG Yu-dou,YUAN Xia. Meta-analysis of the effect of Compound Methenamin Capsules in the treatment of cough after respiratory infection[J]. 中国当代医药, 2020, 27(16): 7-10.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I16/7

[1]	Braman SS.Postinfectious cough：ACCP evidence-based clinical practice guidelines[J].Chest，2006，129（1 Suppl）：138S-146S.
[2]	沈蔚，张梅，周文荣，等.慈溪市亚急性咳嗽病因分别及临床特征分析[J].现代实用医学，2016，28（2）：257-259.
[3]	中华医学会呼吸学会分会哮喘组.咳嗽的诊断与治疗指南（2015）[J].中华结核和呼吸杂志，2016，39（5）：323-328.
[4]	周新，包婺平，瞿介明，等.复方甲氧那明治疗感染后咳嗽的有效性和安全性多中心临床研究[J].国际呼吸杂志，2011，31（23）：1761-1765.
[5]	李善群，吴小丹，黄建浩，等.复方甲氧那明胶囊治疗轻中度支气管哮喘[J].中国临床医学，2006，13（6）：918-919.
[6]	杨立丽，张莉.复方甲氧那明治疗上呼吸道感染后咳嗽的临床疗效[J].临床合理用药杂志，2015，36（8）：11-13.
[7]	祝锡聪，张霞.复方甲氧那明治疗感染后咳嗽的临床疗效[J].山西医科大学学报，2012，43（1）：30-32.
[8]	王薿.复方甲氧那明治疗感染后咳嗽的有效性和安全性[J].中国社区医师，2018，34（19）：60-62.
[9]	岳圆圆，李忠梅.复方甲氧那明治疗感染后咳嗽的有效性及可行性分析[J].中国卫生产业，2014，10（34）：116-117.
[10]	黄沆，吴冠仪.复方甲氧那明治疗感染后咳嗽的临床效果观察[J]中国基层医药，2019，26（12）：1443-1446.
[11]	季金森.复方甲氧那明治疗感染后咳嗽的疗效和安全性分析[J].中国现代药物应用，2019，13（2）：89-91.
[12]	石苗苗，马瑶，穆清爽.复方甲氧那明治疗感染后咳嗽的疗效和安全性分析[J].转化医学电子杂志，2016，3（8）：6-8.
[13]	毋海英.复方甲氧那明治疗感染后咳嗽的疗效分析[J].北方药学，2014，11（3）：29-31.
[14]	万雨明，王秀红，黄俊华.复方甲氧那明治疗感染后咳嗽110 例[J].中国新药与临床杂志，2010，29（7）：558-560.
[15]	刘铭.系统评价、meta-分析设计与实施方法[M].北京：人民卫生出版社，2011：69-71.